Beijing Ted Pharmaceutical imitation of class 4 benzene shun aku ammonium injection into the administrative approval stage

Benzodiamin is a medium-acting, non-depolarized skeletal muscle relaxant with a hetero-phenylate structure that can be used as an auxiliary drug for whole hemp or as a sedative in the intensive care unit (ICU), which relaxes skeletal muscles and makes tracheal intlection and mechanical aeration easy to carry out.
meters of intranet data show that in 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal benzene shun aquku ammonium injection sales of more than 2.5 billion yuan, an increase of 9.66 percent year-on-year, the first half of 2020 affected by the epidemic, the growth rate has declined.
In the first half of 2020, China's public medical institutions terminal benzene Shun Aquku ammonium injection manufacturers competitive pattern, Hengrui Pharmaceutical dominance is difficult to shake, the exclusive market share of more than 70%, shanghai Pharmaceutical Dongying with 16.75 percent of the market share immediately followed.
data show that at present, only Hengrui Pharmaceutical submitted a supplementary application for the consistent evaluation of benzene shun aquco ammonium injection, Qilu, Yangzijiang, Beijing Ted Pharmaceuticals and other enterprises to a new classification of production, of which Beijing Ted Pharmaceutical products have entered the administrative approval stage;
。